IP Library Granted Patent US 11,944,653
Granted Patent B2
US 11,944,653 · App. 18/112,785 · Granted Apr 2, 2024

Compositions and methods for diagnosing and treating degenerative mitral valve disease in a canine

Inventor: Qinghong Li (Chesterfield, MO)
Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
A61K35/74A23K10/16A23K50/40C12Q1/689
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,944,653
App. No.
18/112,785
Granted
Apr 2, 2024
Kind
B2
Abstract

Methods and compositions diagnose and treat degenerative mitral valve disease in a canine. A method of treating or slowing progression of degenerative mitral valve disease in a canine can include administering a composition to the canine, and the composition contains at least one probiotic that is Butyricicoccus and/or Faecalibacterium The composition can be a pet food or administered in conjunction with a pet food.

Claims (9)

1. A method of treating or slowing progression of degenerative mitral valve disease in a canine, the method comprising administering a composition to the canine, wherein the composition comprises at least one probiotic selected from the group consisting of Butyricicoccus and Faecalibacterium .

2. The method of claim 1 , wherein the at least one probiotic comprises Butyricicoccus .

3. The method of claim 2 , wherein the administering is on a regular basis.

4. The method of claim 2 , wherein the composition is administered in conjunction with a pet food composition.

5. The method of claim 2 , wherein the composition is a pet food.

6. The method of claim 1 , wherein the at least one probiotic comprises Faecalibacterium comprising Faecalibacterium prausnitzii .

7. The method of claim 1 , wherein the administering is on a regular basis.

8. The method of claim 1 , wherein the composition is administered in conjunction with a pet food composition.

9. The method of claim 1 , wherein the composition is a pet food.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2024
From: LI, QINGHONG
To: NESTEC S.A.
Reel/Frame 066530/0578 →
MERGER Recorded Feb 22, 2024
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 066647/0390 →
Continuity (3)
Division 16716842 · Dec 17, 2019
Provisional Application 62785373 · Dec 27, 2018
Related Publication 20230407410A1 · Dec 21, 2023